When Is Telemedicine Appropriate in the Management of Head and Neck Cancer? A Mixed-Methods Assessment Among Patients and Physicians.
Tony K W HungNicholas P VerdiniJaime L GillilandSusan ChimonasJennifer R CracchioloYuelin LiDavid G PfisterErin F GillespiePublished in: JCO oncology practice (2024)
Patient experience with telemedicine is diverse among the HNC population. Notably, patients with thyroid cancer had overall better experience and were identified to be more appropriate for telemedicine compared with other patients with HNC. Future research that optimizes patient experience and selection is needed to ensure successful integration of telemedicine into routine oncology practice.